We are continuously collaborating with medical professionals and experts across the globe to bring the latest technologies and innovation to new therapies for neurovascular intervention. Our TWIN (Tubridge & Willis) solutions offer surgeons complete tool sets for resolving potential issues during hemorrhagic stroke. Through minimally invasive means, surgeons can perform both rapid repair of ruptured blood vessel walls through stent grafts, and isolation of aneurysm through blood flow redirection devices.
Hemorrhagic Cerebrovascular Solutions
Hemorrhagic stroke is a leading cause of death across the globe, commonly caused by aneurysm ruptures. MicroPort® NeuroTech is committed to foster rapid communication with physicians, and collaborate to jointly develop new products, and provide complete surgical solutions for patients with hemorrhagic stroke. At present, we have launched a novel blood flow diverter device to the market, as well as the world's first intracranial stent graft.
Ischemic Cerebrovascular Solutions
Ischemic stroke is usually caused by stenosis or occlusion of the blood artery, resulting in insufficient cerebral blood supply and subsequent necrosis of brain tissues. Ischemic stroke is associated with high rates of death and disability. Through many years of close collaboration with physicians, MicroPort® NeuroTech has developed intracranial balloon dilated stents for the treatment of ischemic stroke caused by intracranial atherosclerosis.